Aims & Scope
Chinese Herbal Medicines (CHM) is a peer-reviewed journal sponsored by Tianjin Institute of Pharmaceutical Research and Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences.
CHM is an international quarterly-published journal with the aim at pioneering in the research trend of herbal medicines from different countries or regions and providing a forum for the theoretical and clinical studies on traditional medicines, herbal medicines and natural products.
The journal covers researches on medicinal materials and resources, active constituents (including biosynthesis, tissue culture, etc.), classical and complex formulae (including compatibility and incompatibility of prescriptions, pharmaceutics and technology), quality evaluation and safety, authentication (including molecular and morphological identification, etc.) of herb medicines in phytochemistry, pharmacology, toxicology, pharmacokinetics, and therapeutic function through experimental and clinical trials.
The journal is intended to disseminate the latest developments and research progress in traditional and herbal medical sciences to researchers, practitioners, academics and administrators worldwide in the field of traditional and herbal medicines.
The journal's international coverage ensures that research and progress from all regions of the world are widely included.
Article types accepted by CHM include, but are not limited to, editorials, original articles, reviews, short communications, and book reviews.
Headed by experienced and internationally recognized Editors-in-Chief and supported by the well-represented international editorial board, CHM aims to be developed into a leading journal in the field of traditional and herbal medicine, and to become a communication bridge between traditional medicine and modern medicine.
View Aims & ScopeMetrics & Ranking
Impact Factor
Year | Value |
---|---|
2025 | 8.9 |
Journal Rank
Year | Value |
---|---|
2024 | 5691 |
Journal Citation Indicator
Year | Value |
---|---|
2024 | 1502 |
SJR (SCImago Journal Rank)
Year | Value |
---|---|
2024 | 0.900 |
Quartile
Year | Value |
---|---|
2024 | Q1 |
h-index
Year | Value |
---|---|
2024 | 25 |
Impact Factor Trend
Abstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.
Licensing & Copyright
This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.
Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.
Policy Links
This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.
- Aims scope
- Homepage
- Oa statement
- Author instructions
- License terms
- Review url
- Board url
- Copyright url
- Plagiarism url
- Preservation url
- Apc url
- License
Plagiarism Policy
This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.
For more details, please refer to our official: Plagiarism Policy.
APC Details
The journal’s Article Processing Charge (APC) policies support open access publishing in Medicine and Pharmacology, Toxicology and Pharmaceutics, ensuring accessibility and quality in research dissemination.
This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 1,200.00 USD. Learn more.
Explore journals without APCs for alternative publishing options.
Most Cited Articles
The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.
-
A New Concept on Quality Marker for Quality Assessment and Process Control of Chinese Medicines
Citation: 88
Authors: Chang-xiao, Yi-yu, De-an, Tie-jun, Ya-zhuo, Wen-bin, Lu-qi, Hai-yu
-
Network Pharmacology-based Approaches Capture Essence of Chinese Herbal Medicines
Citation: 63
Authors: Yan-qiong, Xia, Qiu-yan, Na, Shao
-
Research progress of Chinese herbal medicine compounds and their bioactivities: Fruitful 2020
Citation: 60
Authors: Xiaojie, Dacheng, Peigen
-
Pharmaceutical resource discovery from traditional medicinal plants: Pharmacophylogeny and pharmacophylogenomics
Citation: 57
Authors: Da-cheng, Pei-gen
-
Network Pharmacology Bridges Traditional Application and Modern Development of Traditional Chinese Medicine
Citation: 48
Authors: Chang-xiao, Rui, Hui-rong, Xue-feng, Xiao-peng, Hai-yu, Yan-ping
-
A Review of Quality Assessment and Grading for Agarwood
Citation: 44
Authors: Yang-yang, Jian-he, Zhi-hui, Zheng, Jun-chen
-
Chemical constituents and pharmacological activities of medicinal plants from Rosa genus
Citation: 41
Authors: Yansheng, Yanmin, Xinnan, Jingyang, Jingze, Dailin
-
Chinese herbal medicines for treating ulcerative colitis via regulating gut microbiota-intestinal immunity axis
Citation: 40
Authors: Yifei, Yi, Long, Fang, Mingxing, Qin, Haoming, Qianyun, Jiuping, Yueshui, Fukuan, Yu, Jing, Shulin, Zhangang, Xu